Renal Hypothermia During Partial Nephrectomy

Sponsor
Ottawa Hospital Research Institute (Other)
Overall Status
Unknown status
CT.gov ID
NCT01529658
Collaborator
Canadian Institutes of Health Research (CIHR) (Other)
184
6
2
60
30.7
0.5

Study Details

Study Description

Brief Summary

The Objective is to determine if renal hypothermia during open partial nephrectomy results in improved post-operative renal function compared to warm ischemia.

Primary Aim is to determine the effect of hypothermia on preservation of overall renal function compared to no hypothermia in patients who require hilar vessel clamping during open partial nephrectomy for a renal tumor.

Hypothesis: Hypothermia will result in improved post-operative preservation of overall renal function.

Secondary Aim is to determine the effect of hypothermia on preservation of affected renal function (kidney with the tumor) compared to no hypothermia in patients who require hilar vessel clamping during open partial nephrectomy for a renal tumor.

Hypothesis: Hypothermia will result in improved post-operative preservation of affected renal function.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Renal hypothermia
N/A

Detailed Description

The incidence of renal cell carcinoma is increasing and in 2008 it is estimated that over 51,000 new renal cancers will be diagnosed in the United States. To preserve renal function, urologists commonly remove the diseased segment of the kidney (partial nephrectomy) instead of removing the entire kidney (radical nephrectomy). While the benefit of preserving function in patients with renal cell carcinoma has become clear, optimal preservation techniques are yet to be determined. Specifically, the role of hypothermia during partial nephrectomy has been inadequately studied despite theoretical benefit. The investigators objective is to assess the effectiveness of renal hypothermia during partial nephrectomy. The investigators hypothesis is that renal hypothermia during partial nephrectomy results in improved post-operative renal function compared to warm ischemia.

Methods: To test the investigators hypothesis, 180 partial nephrectomy patients will be randomized to cold or warm ischemia. Global and side-specific renal function will be assessed pre-operatively and 12 months post-operatively using radionucleotide clearance and renal scintigraphy.

Significance: To the investigators knowledge, this study will be the first prospective trial to evaluate the clinical impact of renal hypothermia during partial nephrectomy. Since renal function preservation is the primary purpose of partial nephrectomy, these findings will have an important impact on surgical technique and patient outcome.

Study Design

Study Type:
Interventional
Actual Enrollment :
184 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
A Randomized Controlled Trial of Renal Hypothermia During Partial Nephrectomy
Study Start Date :
Sep 1, 2012
Anticipated Primary Completion Date :
Sep 1, 2017
Anticipated Study Completion Date :
Sep 1, 2017

Arms and Interventions

Arm Intervention/Treatment
No Intervention: No hypothermia

After clamping of the renal vessels, no ice slush will be used.

Experimental: Hypothermia

saline ice slush around kidney for 10 minutes.

Procedure: Renal hypothermia
Within 10 seconds of clamping the renal vessels, the kidney will be encased with saline ice slush for a period of 10 minutes. The slush will be created from sterile saline using an operating room slush machine. The slush is applied by the surgeon and lightly packed around the kidney to ensure complete coverage with at least a 2 cm layer. Slush removal is performed by the surgeon beginning at the 10 minute mark. Enough slush is removed to uncover the tumour area. Surgical incision of the kidney begins as soon as the tumour area is uncovered. When reconstruction of the kidney is complete, the slush is completely removed from the surgical field and the clamps are removed from the renal vein and artery.
Other Names:
  • Ice
  • Outcome Measures

    Primary Outcome Measures

    1. Renal function [12 months]

      Glomerular filtration rate will be measured using the plasma clearance of 99mTc-DTPA.

    Secondary Outcome Measures

    1. Difference in affected renal function [12 months]

      Side-specific renal function will be calculated by the product of overall glomerular filtration (determined from 99mTc-DTPA plasma clearance) and relative renal contribution (determined from 99mTc-DTPA renal scintigraphy).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients presenting with a renal mass deemed amenable to an open partial nephrectomy regardless of stage, histology, presence of solitary kidney, multiple tumors or renal function. Participating surgeons will identify patients they consider to be appropriate candidates for partial nephrectomy with or without renal hypothermia.

    • Willing to consent to randomization

    • Willing to comply with study protocol

    Exclusion Criteria:
    • Bilateral renal tumours with planned surgery either partial or radical nephrectomy on the contralateral kidney within the 12 months of the study.

    • Life expectancy < 3 months as deemed by treating physician

    • Age less than 18 years old

    • Pregnancy

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Capital Disctrict Health Authority Halifax Nova Scotia Canada B3H 1V7
    2 St. Joseph's Healthcare Hamilton Ontario Canada L8N 4A6
    3 London Health Science Centre London Ontario Canada N6C 2R5
    4 The Ottawa Hospital Ottawa Ontario Canada K1y 4E9
    5 University Health Network Toronto Ontario Canada M5G 2N2
    6 Centre hospitalier universitaire de Québec Québec Quebec Canada G1R 2J7

    Sponsors and Collaborators

    • Ottawa Hospital Research Institute
    • Canadian Institutes of Health Research (CIHR)

    Investigators

    • Principal Investigator: Ilias Cagiannos, MD, The Ottawa Hospital, Ottawa Hospital Research Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ottawa Hospital Research Institute
    ClinicalTrials.gov Identifier:
    NCT01529658
    Other Study ID Numbers:
    • 2010-767; CIHR MOP 269009
    First Posted:
    Feb 9, 2012
    Last Update Posted:
    Oct 27, 2016
    Last Verified:
    Oct 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Ottawa Hospital Research Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 27, 2016